CLARITY MEDICAL: Hong Kong Court Rejects Shareholder Lawsuit in Full

Bulletin Express
04/02

Clarity Medical Group Holding Limited announced that the High Court of Hong Kong has dismissed in its entirety the Originating Summons (HCMP 1627/2025) filed by shareholder Tse Wai Ip. The ruling, delivered at a hearing on 2 April 2026, strikes out all reliefs sought by the plaintiff.

The Court indicated that detailed written reasons will be handed down in due course. No further legal or financial implications were disclosed in the announcement.

As at 2 April 2026, Clarity Medical’s Board consists of one executive director, three non-executive directors and four independent non-executive directors, led by Executive Director and Chief Executive Officer Jiang Bo.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10